Related references
Note: Only part of the references are listed.Ovarian Cancer, Version 2.2020
Deborah K. Armstrong et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
TTK inhibitor promotes radiosensitivity of liver cancer cells through p21
Haibo Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Mitotic checkpoint kinase Mps1/TTK predicts prognosis of colon cancer patients and regulates tumor proliferation and differentiation via PKCα/ERK1/2 and PI3K/Akt pathway
Li Zhang et al.
MEDICAL ONCOLOGY (2020)
Upregulation of Thr/Tyr kinase Increases the Cancer Progression by Neurotensin and Dihydropyrimidinase-Like 3 in Lung Cancer
Ying-Ming Tsai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination
Benjamin C. Chandler et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Participation of the ATR/CHK1 pathway in replicative stress targeted therapy of high-grade ovarian cancer
Patrycja Gralewska et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Treating Cancer by Spindle Assembly Checkpoint Abrogation: Discovery of Two Clinical Candidates, BAY 1161909 and BAY 1217389, Targeting MPS1 Kinase
Volker K. Schulze et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
TTK regulates proliferation and apoptosis of gastric cancer cells through the Akt-mTOR pathway
Hongxia Huang et al.
FEBS OPEN BIO (2020)
PBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma
Hanlin Ma et al.
CELL DEATH & DISEASE (2019)
Silencing TTK expression inhibits the proliferation and progression of prostate cancer
Saipeng Chen et al.
EXPERIMENTAL CELL RESEARCH (2019)
Down-regulation of OGT promotes cisplatin resistance by inducing autophagy in ovarian cancer
Fuxing Zhou et al.
THERANOSTICS (2018)
Genetic and pharmacological inhibition of TTK impairs pancreatic cancer cell line growth by inducing lethal chromosomal instability
Jeran K. Stratford et al.
PLOS ONE (2017)
Rad52 phosphorylation by Ipl1 and Mps1 contributes to Mps1 kinetochore localization and spindle assembly checkpoint regulation
Gyubum Lim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer
Jacqueline M. Mason et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Protein Phosphatase 1 inactivates Mps1 to ensure efficient Spindle Assembly Checkpoint silencing
Margarida Moura et al.
ELIFE (2017)
Characterisation of CCT271850, a selective, oral and potent MPS1 inhibitor, used to directly measure in vivo MPS1 inhibition vs therapeutic efficacy
Amir Faisal et al.
BRITISH JOURNAL OF CANCER (2017)
Molecular basis underlying resistance to Mps1/TTK inhibitors
A. Koch et al.
ONCOGENE (2016)
HLF/miR-132/TTK axis regulates cell proliferation, metastasis and radiosensitivity of glioma cells
Shu Chen et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Recent insights into the function of autophagy in cancer
Ravi Amaravadi et al.
GENES & DEVELOPMENT (2016)
ARHGEF17 is an essential spindle assembly checkpoint factor that targets Mps1 to kinetochores
Mayumi Isokane et al.
JOURNAL OF CELL BIOLOGY (2016)
Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle Kinase 1 (MPS1) Using a Structure-Based Hybridization Approach
Paolo Innocenti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Novel Mps1 Kinase Inhibitors with Potent Antitumor Activity
Antje M. Wengner et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model
A. R. R. Maia et al.
ANNALS OF ONCOLOGY (2015)
A unique hinge binder of extremely selective aminopyridine-based Mps1 (TTK) kinase inhibitors with cellular activity
Ken-ichi Kusakabe et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Discovery of Imidazo[1,2-b]pyridazine Derivatives: Selective and Orally Available Mps1 (TTK) Kinase Inhibitors Exhibiting Remarkable Antiproliferative Activity
Ken-ichi Kusakabe et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
The Discovery of Orally Bioavailable Tyrosine Threonine Kinase (TTK) Inhibitors: 3-(4-(heterocyclyl)phenyl)-1H-indazole-5-carboxamides as Anticancer Agents
Yong Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Targeting MPS1 Enhances Radiosensitization of Human Glioblastoma by Modulating DNA Repair Proteins
Uday Bhanu Maachani et al.
MOLECULAR CANCER RESEARCH (2015)
Dynamic localization of Mps1 kinase to kinetochores is essential for accurate spindle microtubule attachment
Zhen Dou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Joined at the hip: kinetochores, microtubules, and spindle assembly checkpoint signaling
Carlos Sacristan et al.
TRENDS IN CELL BIOLOGY (2015)
TTK activates Akt and promotes proliferation and migration of hepatocellular carcinoma cells
Xing Liu et al.
ONCOTARGET (2015)
Role of Autophagy in Cisplatin Resistance in Ovarian Cancer Cells
Juan Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
PP2A-B56 opposes Mps1 phosphorylation of Knl1 and thereby promotes spindle assembly checkpoint silencing
Antonio Espert et al.
JOURNAL OF CELL BIOLOGY (2014)
Expression and Function Analysis of Mitotic Checkpoint Genes Identifies TTK as a Potential Therapeutic Target for Human Hepatocellular Carcinoma
Xiao-Dong Liang et al.
PLOS ONE (2014)
Characterization of novel MPS1 inhibitors with preclinical anticancer activity
M. Jemaa et al.
CELL DEATH AND DIFFERENTIATION (2013)
The MPS1 Family of Protein Kinases
Xuedong Liu et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 81 (2012)
The Spindle Assembly Checkpoint
Pablo Lara-Gonzalez et al.
CURRENT BIOLOGY (2012)
MutS homologue hMSH5: role in cisplatin-induced DNA damage response
Joshua D. Tompkins et al.
MOLECULAR CANCER (2012)
Structural basis for cisplatin DNA damage tolerance by human polymerase η during cancer chemotherapy
Ajay Ummat et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
Deconvoluting the context-dependent role for autophagy in cancer
Eileen White
NATURE REVIEWS CANCER (2012)
Synthesis and SAR of new pyrazolo[4,3-h]quinazoline-3-carboxamide derivatives as potent and selective MPS1 kinase inhibitors
Marina Caldarelli et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Characterization of the Cellular and Antitumor Effects of MPI-0479605, a Small-Molecule Inhibitor of the Mitotic Kinase Mps1
Keith D. Tardif et al.
MOLECULAR CANCER THERAPEUTICS (2011)
High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells
Jewel Daniel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Rethinking ovarian cancer: recommendations for improving outcomes
Sebastian Vaughan et al.
NATURE REVIEWS CANCER (2011)
Targeting the Mitotic Checkpoint for Cancer Therapy with NMS-P715, an Inhibitor of MPS1 Kinase
Riccardo Colombo et al.
CANCER RESEARCH (2010)
Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function
Nicholas Kwiatkowski et al.
NATURE CHEMICAL BIOLOGY (2010)
Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies
S. Sarkar et al.
CELL DEATH AND DIFFERENTIATION (2009)
Cdc7 Kinase Is a Predictor of Survival and a Novel Therapeutic Target in Epithelial Ovarian Carcinoma
Anjana A. Kulkarni et al.
CLINICAL CANCER RESEARCH (2009)
Chemical genetics reveals a role for Mps1 kinase in kinetochore attachment during mitosis
MH Jones et al.
CURRENT BIOLOGY (2005)
Share Paper
